NRX Therapeutics: Buy Rating Maintained, PT Raised to $34 by D. Boral Capital.

lunes, 5 de enero de 2026, 8:48 am ET1 min de lectura
NRXP--

NRX Therapeutics: Buy Rating Maintained, PT Raised to $34 by D. Boral Capital.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios